Condition: Tuberculosis · Mycobacterium Tuberculosis · Sponsor: University Children's Hospital Basel
1. The primary objective is to improve the sensitivity of novel immunodiagnostic tests for detection of TB disease in children. 2. The secondary objective is to determine biomarkers that discriminate children with TB infection and disease.
This description comes directly from the study's public registry record.
Nina Vaezipour, Dr med · +41617042947 · nina.vaezipour@ukbb.ch
Nicole Ritz, Prof Dr med PhD · +41617042947 · nicole.ritz@unibas.ch
Always discuss trial participation with your own doctor first.
| Kantonspital Aarau | Aarau, Switzerland | Recruiting |
| Nina Vaezipour | Basel, Switzerland | Recruiting |
| Ospedale Regionale di Bellinzona | Bellinzona, Switzerland | Recruiting |
| Inselspital Bern | Bern, Switzerland | Recruiting |
| Hôpital des enfants - HUG | Geneva, Switzerland | Recruiting |
| Kinserspital Luzern | Lucerne, Switzerland | Recruiting |
| Kinderspital St Gallen | Sankt Gallen, Switzerland | Recruiting |
| Kinderklinik Zürich | Zurich, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03044509